ImmunaBand Launches Wearable Designed to Digitally Access your COVID-19 Vaccination Documentation
ImmunaBand, the first-to-market wearable COVID-19 vaccination documentation to signify an individual's vaccination status, announced their public launch.
As the pace of vaccine distribution quickens and as new CDC guidelines allowing vaccinated individuals to gather without masks are announced, easily demonstrating vaccination statuses will become increasingly important. ImmunaBand's proprietary wristband will show immunization status to anyone with a smartphone.
The ImmunaBand is a stylish blue silicone bracelet emblazoned with the words "COVID-19 Vaccinated." Each bracelet has a metal tag with an engraved, unique QR code which, when scanned by a smartphone, directs users to their personal password-protected vaccination record.
To purchase an ImmunaBand, customers must complete a COVID-19 vaccination that has received FDA Emergency Authorization and upload their vaccination card documenting that status to ImmunaBand's HIPAA-compliant server. The vaccination card storage process is end-to-end encrypted to ensure data privacy and security.
As the pace of vaccine distribution quickens and as new CDC guidelines allowing vaccinated individuals to gather without masks are announced, easily demonstrating vaccination statuses will become increasingly important. ImmunaBand's proprietary wristband will show immunization status to anyone with a smartphone.
The ImmunaBand is a stylish blue silicone bracelet emblazoned with the words "COVID-19 Vaccinated." Each bracelet has a metal tag with an engraved, unique QR code which, when scanned by a smartphone, directs users to their personal password-protected vaccination record.
To purchase an ImmunaBand, customers must complete a COVID-19 vaccination that has received FDA Emergency Authorization and upload their vaccination card documenting that status to ImmunaBand's HIPAA-compliant server. The vaccination card storage process is end-to-end encrypted to ensure data privacy and security.
No comments: